Skip to main content
    K

    Kiniksa Pharmaceuticals Ltd (KNSA)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $95.11
    +0.88 (+0.93%)

    Market Cap: $7.40B

    Last updated: Nov 17, 2026 at 4:38 PM ET

    Kiniksa Pharmaceuticals Ltd (KNSA) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Kiniksa Pharmaceuticals (KNSA) has a latest price of $95.11 on Nov 17, 2026, 4.2% below its 52-week high of $99.31. Its price rose 135.9% over the past 12 months. The month-end price rose 439.1% since May 2018, a compound annual rate of 22.2%.

    Price Chart

    From May 2018 to Oct 2026, its highest month-end close was $92.24 in Oct 2026 and its lowest $7.05 in Oct 2019, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart KNSA with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for KNSA.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price rose 17.7%, and over 6 months it rose 78.3%. The month-end price rose 504.9% over the 3 years through Oct 2026, a compound annual rate of 82.2%.

    PeriodChange
    1 month+19.7%
    3 months+17.7%
    6 months+78.3%
    12 months+135.9%
    12 months, with dividends+135.9%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+504.9%+82.2%
    5 years+787.8%+54.8%
    Since May 2018+439.1%+22.2%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2025, when the price rose 108.5%, and its weakest was 2019, when it fell 60.6%.

    YearCloseChange
    2026 through Oct 2026$92.24+123.6%
    2025$41.25+108.5%
    2024$19.78+12.8%
    2023$17.54+17.1%
    2022$14.98+27.3%
    2021$11.77-33.4%
    2020$17.67+59.8%
    2019$11.06-60.6%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 14.8% above its 50-day average of $82.86 and 50.2% above its 200-day average of $63.33.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$95.11
    52-week high$99.31-4.2%
    52-week low$37.02+156.9%
    50-day average$82.86+14.8%
    200-day average$63.33+50.2%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 34.1%.

    MeasureValue
    1-year beta0.60
    Largest fall, 1 year-21.1%
    Largest fall, 3 years-34.1%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About KNSA

    What is KNSA's 1-year price change?

    Kiniksa Pharmaceuticals's price rose 135.9% over the past 12 months. With dividends included, the 12-month total return was 135.9%.

    What is KNSA's 5-year price change?

    Kiniksa Pharmaceuticals's month-end price rose 787.8% over the 5 years through Oct 2026, a compound annual rate of 54.8%. These figures leave out dividends.

    What is KNSA's 52-week high and low?

    Kiniksa Pharmaceuticals's 52-week high is $99.31 and its 52-week low is $37.02. Its latest price of $95.11 on Nov 17, 2026 is 4.2% below the high.

    What is KNSA's beta?

    Kiniksa Pharmaceuticals's 1-year beta against the S&P 500 is 0.60, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 21.1%.

    Is the KNSA chart free?

    Yes. Advanced Charting for KNSA is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.